Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1871-1880 of 2933 for cancer

Edit search filters
  1. A Study To Evaluate T-DM1 With Or Without Abemaciclib In Women And Men With HER2-positive Advanced Or Metastatic Breast Cancer

    Jacksonville, FL, Rochester, MN

  2. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

    Rochester, MN

  3. Isatuximab In Treating Patients With Relapsed Or Refractory Primary Amyloidosis

    Rochester, MN

  4. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial

    Rochester, MN

  5. A Study To Evaluate Clinical Transplant-Related Long-term Outcomes Of Alternative Donor Allogeneic Transplantation

    Rochester, MN

  6. Erlotinib Hydrochloride And Cabozantinib-s-Malate Alone Or In Combination As Second Or Third Line Therapy In Treating Patients With Stage IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. Specialized Radiation Therapy And Chemotherapy In Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study To Evaluate The Effectiveness And Safety Of Rivaroxaban As Prophylaxis Treatment For Venous Thromboembolism (VTE) In Ambulatory Cancer Patients

    Rochester, MN

  9. A Clinical Study Of MK-1084 With Targeted Therapy And Chemotherapy In People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Of Pembrolizumab Alone Or Combined With CC-486 For Patients With Platinum-Resistant Ovarian, Fallopian Tube, Or Peritoneal Cancer

    Rochester, MN

.

Mayo Clinic Footer